According to Advaxis's latest financial reports the company's current EPS (TTM) is -$5.97. In 2021 the company made an earnings per share (EPS) of -$2.83 a decrease over its 2020 EPS that were of -$2.60.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -$5.97 | |
2021 | -$2.83 | 8.65% |
2020 | -$2.60 | 25.61% |
2019 | -$2.07 |
Company | EPS | EPS differencediff. | Country |
---|---|---|---|
Genocea Biosciences
GNCA | -$0.52 | -91.29% | ๐บ๐ธ USA |
Inovio Pharmaceuticals INO | -$0.65 | -89.11% | ๐บ๐ธ USA |
Heska Corporation
HSKA | -$1.93 | -67.67% | ๐บ๐ธ USA |